Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo
Diseases of the Nervous System
What is the purpose of this trial?
Patients with partial seizures currently taking 1-3 antiepileptic medications will have a 50:50 chance to receive Lyrica 300 mg per day or placebo (no active ingredients) added on to their current medications for 3 months. Neither the study doctor nor the patient will know the medication assignment. Vision testing will be performed prior to receiving the study treatment and at the end of the study to see if there are any changes.
- Ages18 - 65 years
- Trial withPfizer Inc., U.S. Pharmaceuticals Group
- Start Date10/14/2015
- End Date11/29/2019
- Last Updated02/22/2018
- Study HIC#1401013207